CTNM Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Contineum Therapeutics Inc (CTNM) Moving Averages Convergence Divergence (MACD) indicator is 0.641, suggesting CTNM is Buy.

Contineum Therapeutics Inc (CTNM) 20-Day simple moving average is 15.217, while Contineum Therapeutics Inc (CTNM) share price is $14.91, making it Sell.

Contineum Therapeutics Inc (CTNM) 60-Day simple moving average is 12.934, while Contineum Therapeutics Inc (CTNM) share price is $14.91, making it Buy.

Technical Analysis for CTNM

Technical Sentiment Analysis for Contineum Therapeutics Inc (CTNM) As of 2026-03-02, Contineum Therapeutics Inc (CTNM) is exhibiting a Buy technical sentiment. Our proprietary analysis, which aggregates 11 technical signals, shows that 7 indicators are flashing buy, while 4 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for CTNM stands at 53.037, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.641, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 58.18 and the Commodity Channel Index (CCI) at -59.222 further confirm a 0.47 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, CTNM is trading above its 60-day moving average of $12.934 and above its 200-day long-term moving average of $9.586. Key price levels to watch include the immediate resistance at $16.518 and strong support at $14.268. A break above $16.518 could signal a bull continuation, while falling below $14.268 may test the next Fibonacci floor at $13.049.

Contineum Therapeutics Inc (CTNM) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	12.018	13.049	14.268	15.299	16.518	17.549	18.768
Fibonacci	13.049	13.909	14.44	15.299	16.159	16.689	17.549

Contineum Therapeutics Inc (CTNM) Technical Indicators

2026-03-02

Name	Value
RSI_14	53.037
STOCHk_14_3_3	58.18
STOCHd_14_3_3	69.911
CCI_20	-59.222
AO_5_34	1.499
MOM_10	0.47
MACD_12_26_9	0.641

Contineum Therapeutics Inc (CTNM) Relative Strength Index (RSI) is 53.037, creating a Neutral signal.

Contineum Therapeutics Inc (CTNM) Stochastic Oscillator is 58.18, creating a Neutral signal.

Contineum Therapeutics Inc (CTNM) Stochastic RSI is 69.911, creating a Neutral signal.

Contineum Therapeutics Inc (CTNM) Commodity Channel Index (CCI) is -59.222, creating a Neutral signal.

Contineum Therapeutics Inc (CTNM) Awesome Oscillator is 1.499, creating a Buy signal.

Contineum Therapeutics Inc (CTNM) Momentum is 0.47, creating a Buy signal.

Contineum Therapeutics Inc (CTNM) MACD is 0.641, creating a Buy signal.

Contineum Therapeutics Inc (CTNM) Moving Average

2026-03-02

Period	Simple	Signal
MA_5	15.548	Sell
MA_10	15.487	Sell
MA_20	15.217	Sell
MA_60	12.934	Buy
MA_200	9.586	Buy
MA_250	8.788	Buy

Contineum Therapeutics Inc (CTNM) 5-Day simple moving average is 15.548, while Contineum Therapeutics Inc (CTNM) share price is $14.91, making it a Sell.

Contineum Therapeutics Inc (CTNM) 10-Day simple moving average is 15.487, while Contineum Therapeutics Inc (CTNM) share price is $14.91, making it a Sell.

Contineum Therapeutics Inc (CTNM) 20-Day simple moving average is 15.217, while Contineum Therapeutics Inc (CTNM) share price is $14.91, making it a Sell.

Contineum Therapeutics Inc (CTNM) 60-Day simple moving average is 12.934, while Contineum Therapeutics Inc (CTNM) share price is $14.91, making it a Buy.

Contineum Therapeutics Inc (CTNM) 200-Day simple moving average is 9.586, while Contineum Therapeutics Inc (CTNM) share price is $14.91, making it a Buy.

Contineum Therapeutics Inc (CTNM) 250-Day simple moving average is 8.788, while Contineum Therapeutics Inc (CTNM) share price is $14.91, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for CTNM?

The overall technical consensus for Contineum Therapeutics Inc (CTNM) is currently Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 1 sell signals.

What are the key support and resistance levels for Contineum Therapeutics Inc (CTNM) today?

Based on pivot point calculations, Contineum Therapeutics Inc (CTNM) has an immediate support level at 14.268 and a major resistance level at 16.518. Traders also monitor the pivot point at 15.299 to determine the intraday trend direction.

Is Contineum Therapeutics Inc (CTNM) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Contineum Therapeutics Inc (CTNM) is currently 53.037. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Contineum Therapeutics Inc (CTNM)?

Contineum Therapeutics Inc (CTNM) Moving Averages Convergence Divergence (MACD) indicator is 0.641, suggesting CTNM is Buy. This indicator helps identify potential trend reversals or momentum shifts for Contineum Therapeutics Inc.

How is Contineum Therapeutics Inc (CTNM) performing relative to its 200-day moving average?

Contineum Therapeutics Inc (CTNM) is currently trading at $14.91, which is above its 200-day simple moving average of 9.586. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.